AbbVie
ABBV
#32
Rank
โ‚น35.435 T
Marketcap
โ‚น20,056
Share price
1.09%
Change (1 day)
33.43%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of December 2025 : โ‚น500.24 Billion

According to AbbVie's latest financial reports the company has โ‚น500.24 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚น471.91 B-0.97%
2024-12-31โ‚น476.54 B-55.33%
2023-12-31โ‚น1.066 T39.7%
2022-12-31โ‚น763.70 B4.38%
2021-12-31โ‚น731.65 B17.99%
2020-12-31โ‚น620.10 B-78.22%
2019-12-31โ‚น2.847 T405.11%
2018-12-31โ‚น563.64 B-9.82%
2017-12-31โ‚น625.03 B43.2%
2016-12-31โ‚น436.47 B-21.88%
2015-12-31โ‚น558.68 B5.27%
2014-12-31โ‚น530.72 B-13.18%
2013-12-31โ‚น611.31 B39.98%
2012-12-31โ‚น436.70 B1164.22%
2011-12-31โ‚น34.54 B7054.46%
2010-12-31โ‚น0.48 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
โ‚น1.293 T 158.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น691.60 B 38.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น868.69 B 73.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น363.09 B-27.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น914.74 B 82.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.015 T 103.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น544.20 B 8.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น404.82 B-19.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น140.87 B-71.84%๐Ÿ‡บ๐Ÿ‡ธ USA